Successful treatment of Glanzmann's Thrombasthenia with recombinant activated Factor VII "NovoSeven"

被引：0
|
作者：
Keikhaei, Bijan [1 ]
机构：
[1] Ahvaz Jundishapur Univ Med Sci, Shafa Hosp, Thalassemia & Hemoglobinopathy Res Ctr, Ahvaz, Iran
来源：
HAEMOPHILIA | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / 102
页数：2
相关论文
共 50 条
  • [1] The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
    Poon, Man-Chiu
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (03) : 332 - 340
  • [2] Approval Extension for activated recombinant Factor VII NovoSeven® can now be used without Antibody Detection in Thrombasthenia Glanzmann
    不详
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2019, 46 (02) : 127 - 127
  • [3] Use of recombinant factor VIIa (NovoSeven®) in patients with Glanzmann thrombasthenia
    Poon, MC
    d'Oiron, R
    Hann, I
    Négrier, C
    de Lumley, L
    Thomas, A
    Karafoulidou, A
    Demers, C
    Street, A
    Huth-Kühne, A
    Petrini, P
    Fressinaud, E
    Morfini, M
    Tengborn, L
    Marquès-Verdier, A
    Musso, R
    Devecioglu, O
    Houston, DS
    Lethagen, S
    Van Geet, C
    von Depka, M
    Berger, C
    Beurrier, P
    Britton, HA
    Gerrits, W
    Guthner, C
    Kuhle, S
    Lorenzo, JJ
    Makris, PE
    Nohe, N
    Paugy, P
    Pautard, B
    Torchet, MF
    Trillot, N
    Vicariot, M
    Wilde, J
    Winter, M
    Chambost, H
    Ingerslev, J
    Peters, M
    Strauss, G
    SEMINARS IN HEMATOLOGY, 2001, 38 (04) : 21 - 25
  • [4] Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature
    Rajpurkar, M.
    Chitlur, M.
    Recht, M.
    Cooper, D. L.
    HAEMOPHILIA, 2014, 20 (04) : 464 - 471
  • [5] Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy
    Gunaydin, Berrin
    Ozkose, Zerrin
    Pezek, Seyda
    JOURNAL OF ANESTHESIA, 2007, 21 (01) : 106 - 107
  • [6] Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy
    Berrin Gunaydin
    Zerrin Ozkose
    Seyda Pezek
    Journal of Anesthesia, 2007, 21 : 106 - 107
  • [7] NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia
    Franchini, Massimo
    Lippi, Giuseppe
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (06) : 733 - 740
  • [8] Experience of recombinant-activated factor VII to control bleeding in children with Glanzmann’s thrombasthenia
    Khair K.
    Svirin P.
    Comparative Clinical Pathology, 2007, 16 (3) : 167 - 172
  • [9] Administration of recombinant factor FVIIa (NovoSeven, NovoNordisk) in a patient with Glanzmann thrombasthenia
    Zyschka, A
    Elanjikal, Z
    Ettingshausen, CE
    Saguer, IM
    Linde, R
    Kreuz, W
    34th Hemophilia Symposium, 2005, : 378 - 379
  • [10] Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia
    Yilmaz, BT
    Alioglu, B
    Ozyurek, E
    Akay, HT
    Mercan, S
    Ozbek, N
    PEDIATRIC CARDIOLOGY, 2005, 26 (06) : 843 - 845
12345